ANNX Q3 2025 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena

ANNXAnnexon, Inc.

$713M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$57M

Net Income

-$55M

EPS (Diluted)

$-0.37

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$52M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$229M

Total Liabilities

$68M

Stockholders' Equity

$161M

Cash & Equivalents

$139M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$57M	-$39M	-44.6%
Net Income	-$55M	-$35M	-57.7%